Related Experiment Videos
Absence seizures aggravated by valproic acid.
T Lerman-Sagie1, N Watemberg, U Kramer
1Pediatric Neurology Unit, Wolfson Medical Center, Holon, Israel. asagie@ccsg.tau.il
Epilepsia
|August 8, 2001
Summary
Valproic acid (VPA) can worsen absence seizures in children with absence epilepsy. This study found that VPA introduction or dose increases led to seizure aggravation in pediatric patients.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Pharmacology
Background:
- Absence epilepsy is a common epilepsy syndrome in children.
- Valproic acid (VPA) is a widely used antiepileptic drug for various seizure types.
- Paradoxical seizure aggravation can occur with antiepileptic drugs in specific epilepsy syndromes.
Purpose of the Study:
- To investigate and report cases of absence seizure aggravation in pediatric patients treated with valproic acid (VPA).
- To analyze the clinical characteristics and EEG findings in children experiencing VPA-induced seizure worsening.
Main Methods:
- Retrospective chart review of pediatric patients diagnosed with absence epilepsy across four epilepsy clinics.
- Inclusion criteria: patients receiving VPA for absence epilepsy between 1994 and 2000.
- Evaluation of seizure frequency, VPA dosage, serum levels, and treatment outcomes.
Main Results:
- Eight pediatric cases (6 boys) of absence seizure aggravation were identified.
- Seizure worsening occurred within days of VPA initiation or dose escalation.
- All patients showed improvement upon VPA discontinuation, with recurrence upon reintroduction in five cases.
Conclusions:
- Valproic acid (VPA) can paradoxically exacerbate absence seizures in a subset of pediatric patients with absence epilepsy.
- This aggravation is not linked to VPA-induced encephalopathy and occurs despite therapeutic serum levels.
- Discontinuation of VPA is effective in managing this adverse effect.